Bcr–Abl activates the AKT/FoxO3 signalling pathway to restrict transforming growth factor‐β‐mediated cytostatic signals
Authors:
- 1 October 2005
- journal article
- Published by Springer Nature in EMBO Reports
- Vol. 6 (10) , 985-991
Abstract
The fusion of Abl with either Bcr or Tel in human leukaemia leads to the constitutive activation of Abl tyrosine kinase, which in turn induces growth‐factor‐independent proliferation and cell survival. However, the mechanism by which Bcr–Abl induces cellular transformation has not yet been well characterized. Here, we show that Bcr–Abl‐expressing cells are resistant to growth inhibition and apoptosis mediated by transforming growth factor‐β (TGF‐β). Interestingly, we observed that the suppressive effects of Bcr–Abl on TGF‐β responses were not mediated by an impairment of Smad signalling, which is believed to act as the principal mediator of TGF‐β responses. In contrast, we found that Bcr–Abl can target the protein kinase AKT and the transcription factor FoxO3 to interfere with growth inhibition and apoptosis in response to TGF‐β. Our results show a novel mechanism of cellular transformation by the oncogenic fusion protein Bcr–Abl through suppression of the cytostatic actions of TGF‐β.Keywords
This publication has 22 references indexed in Scilit:
- Evidence for a Role of MSK1 in Transforming Growth Factor-β-mediated Responses through p38α and Smad Signaling PathwaysJournal of Biological Chemistry, 2004
- Phosphoinositide 3-kinase signaling is essential for ABL oncogene–mediated transformation of B-lineage cellsBlood, 2004
- Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell ProliferationCell, 2004
- Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosisNature Cell Biology, 2004
- PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3Nature Cell Biology, 2004
- TEL/platelet-derived growth factor receptor β activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleBlood, 2002
- Mechanism for Mutational Inactivation of the Tumor Suppressor Smad2Molecular and Cellular Biology, 2001
- Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible EnhancerJournal of Biological Chemistry, 1998
- Molecular and Cell Biology of TGF-βMineral and Electrolyte Metabolism, 1998
- The Dimerization Property of Glutathione -Transferase Partially Reactivates Bcr-Abl Lacking the Oligomerization DomainJournal of Biological Chemistry, 1996